Investing.com - Agenus (NASDAQ:AGEN) reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Agenus announced earnings per share of $-0.190 on revenue of $22.8M. Analysts polled by Investing.com anticipated EPS of $-0.180 on revenue of $19.86M.
Agenus shares are down 20% from the beginning of the year, still down 49.04% from its 52 week high of $4.69 set on November 9, 2021.
Agenus shares gained 3.35% in pre-market trade following the report.
Agenus follows other major Healthcare sector earnings this month
Agenus's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar